In four mouse models, the deletion of TET2 has resulted in progressive expansion of the hematopoietic progenitor compartment, increased hematopoietic stem cell self-renewal and the progressive development of a proliferative myeloid malignancy, similar to CMML.34, 35, 36. The gene discussed is TET2; the disease is chronic myelomonocytic leukemia.